Other Income/Expenses (Net)

$915.81K

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$915.81Kperiod endingJun 30, 2026

APRE TTM Other Income/Expenses (Net) ($1.48M → $915.81K)

TTM Other Income/Expenses (Net)

High-resolution chart · PNG

APRE other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Aprea Therapeutics, Inc. Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period ending	Other Income/Expenses (Net) (USD)
Jun 30, 2026	915,812
Mar 31, 2026	623,839
Dec 31, 2025	634,266
Sep 30, 2025	778,049
Jun 30, 2025	946,318
Mar 31, 2025	1,174,287
Dec 31, 2024	1,360,944
Sep 30, 2024	1,261,373
Jun 30, 2024	1,266,461
Mar 31, 2024	1,282,173
Dec 31, 2023	1,185,207
Sep 30, 2023	1,163,018
Jun 30, 2023	1,020,159
Mar 31, 2023	834,632
Dec 31, 2022	730,201
Sep 30, 2022	594,210
Jun 30, 2022	396,794
Mar 31, 2022	-63,694
Dec 31, 2021	319,050
Sep 30, 2021	-923,589
Jun 30, 2021	-985,426
Mar 31, 2021	-2,619,007
Dec 31, 2020	-667,600
Sep 30, 2020	-591,436
Jun 30, 2020	461,277
Mar 31, 2020	3,024,256
Dec 31, 2019	1,484,491
Sep 30, 2019	2,797,173
Jun 30, 2019	1,620,699